Your browser doesn't support javascript.
Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department.
Beck, Evan J; Hsieh, Yu-Hsiang; Fernandez, Reinaldo E; Dashler, Gaby; Egbert, Emily R; Truelove, Shawn A; Garliss, Caroline; Wang, Richard; Bloch, Evan M; Shrestha, Ruchee; Blankson, Joel; Cox, Andrea L; Manabe, Yukari C; Kickler, Thomas; Rothman, Richard E; Redd, Andrew D; Tobian, Aaron A R; Milstone, Aaron M; Quinn, Thomas C; Laeyendecker, Oliver.
  • Beck EJ; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Hsieh YH; Department of Emergency Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Fernandez RE; Department of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Dashler G; Department of Emergency Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Egbert ER; Department of Pediatrics, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Truelove SA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Garliss C; Department of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Wang R; Department of Emergency Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Bloch EM; Department of Pathology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Shrestha R; Department of Pathology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Blankson J; Department of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Cox AL; Department of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Manabe YC; Department of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Kickler T; Department of Pathology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Rothman RE; Department of Emergency Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Redd AD; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Tobian AAR; Department of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Milstone AM; Department of Pathology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Quinn TC; Department of Pediatrics, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
  • Laeyendecker O; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
J Clin Microbiol ; 60(3): e0239021, 2022 03 16.
Article in English | MEDLINE | ID: covidwho-1765077
ABSTRACT
Emergency departments (EDs) can serve as surveillance sites for infectious diseases. The objective of this study was to determine the burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to monitor the prevalence of vaccination against coronavirus disease 2019 (COVID-19) among patients attending an urban ED in Baltimore City. Using 1,914 samples of known exposure status, we developed an algorithm to differentiate previously infected, vaccinated, and unexposed individuals using a combination of antibody assays. We applied this testing algorithm to 4,360 samples from ED patients obtained in the spring of 2020 and 2021. Using multinomial logistic regression, we determined factors associated with infection and vaccination. For the algorithm, sensitivity and specificity for identifying vaccinated individuals were 100% and 99%, respectively, and 84% and 100% for previously infected individuals. Among the ED subjects, seroprevalence to SARS-CoV-2 increased from 2% to 24% between April 2020 and March 2021. Vaccination prevalence rose to 11% by mid-March 2021. Marked differences in burden of disease and vaccination coverage were seen by sex, race, and ethnicity. Hispanic patients, though accounting for 7% of the study population, had the highest relative burden of disease (17% of total infections) but with similar vaccination rates. Women and white individuals were more likely to be vaccinated than men or Black individuals. Individuals previously infected with SARS-CoV-2 can often be differentiated from vaccinated individuals using a serologic testing algorithm. The utility of this algorithm can aid in monitoring SARS-CoV-2 exposure and vaccination uptake frequencies and can potentially reflect gender, race, and ethnic health disparities.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study Topics: Vaccines Limits: Female / Humans / Male Language: English Journal: J Clin Microbiol Year: 2022 Document Type: Article Affiliation country: Jcm.02390-21

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study Topics: Vaccines Limits: Female / Humans / Male Language: English Journal: J Clin Microbiol Year: 2022 Document Type: Article Affiliation country: Jcm.02390-21